FDA Investigator Amalia C Himaya
Amalia C Himaya has conducted inspections on 4 sites in 1 countries as of 06 Feb 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
4
Last Inspection Date:
06 Feb 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Amalia C Himaya:
Angela Shepas,
Anita Narula, PhD,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Barry Cherney, PhD,
Bichsa T Tran,
Binh T Nguyen,
Bo Chi, PhD,
Brian J Ryan,
Brian P Putz,
Brien C Fox,
Bryan A Galvez,
Carla J Lundi,
Carrie A Hughes,
Caryn M Everly,
Caryn M Mcnab,
Cassandra L Abellard,
Cathleen A Carr Sharpe,
Chelsea N Sealey,
Cheron M Portee,
Christina C Santos,
Christina V Santos,
Christopher D Washington,
Christopher J Freebairn,
Christopher M Jenner,
Daniel W Cline,
Davinna Ligons, PhD,
Diane Cvan Leeuwen,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Esther C Broner, PhD,
Frances Namuswe, PhD,
Haley H Seymour,
Haroon Vohra (NMI),
Hasan A Irier, PhD,
Iris C Macinnes,
James R Fleckenstein,
Jee Chung, PhD,
Jeffrey P Raimondi,
Jennifer Gogley,
Jennifer M Gogley,
Joel Welch, PhD,
Joey V Quitania,
John A Gonzalez,
John R Myung,
Juan J Casado,
Judy C Nepsa,
Julie A Rorberg,
Julie A Stocklin,
Junho Pak,
Ka L Wong,
Kari M Johansen,
Kathleen R Jones, PhD,
Kelley,
Kelvin Cheung,
Kelvin X Sanders,
Kendra A Biddick,
Kham Phommachanh,
Kim Lthomas Cruse,
Laura Fontan, MS,
Leonard H Lavi,
Liming Zhang,
Linda Thai,
Ling Yu L Liu,
Marcia B Williams,
Marcus F Yambot,
Maxyne T Lam,
Michael D Garcia,
Michelle A Marsh,
Mihaly S Ligmond,
Mohsen Rajabi Abhari, FDA,
Natalie J Ayoub,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Omotunde O Osunsanmi,
Peter S Diak,
Rabin N Ghoshal,
Rebecca Rodriguez,
Richard A Abate,
Richard C Chiang,
Richmond K Yip,
Robert D Tollefsen,
Robert Darius,
Roger F Zabinski,
Rona Leblanc, PhD,
Ronald L Koller,
Ronda Leblanc,
Rumany C Penn, PharmD,
Saied A Asbagh,
Sarah Arden,
Scott R Nichols, PhD,
Sean P Desbrow,
Selene T Torres,
Sidney B Priesmeyer,
Sonia R Peterson,
Sonya L Karsik, RAC,
Stanley Au,
Stephanie A Slater, MS,
Steven Fong, MS, PhD,
Sumit Sen,
Taichun Qin, PhD,
Tamala P Magee,
Tamika White,
Tara L Stockton,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
Thomas J Arista,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Vashti E Bocker,
Vickie L Anderson,
Vioela J Caze,
Virgilio F Pacio, CSO,
Walden H Lee,
Yi Lin,
Yumi J Hiramine,
Yvonne C Wilkes,
Yvonne T Lacour,
Zachary A Bogorad
Amalia C Himaya's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2001 | EIR | Amgen, Inc - EIR, 2001-06-08 |
November, 2001 | FDA 483 Response | Bachem Americas, Inc. - Form 483R, 2001-11-27 |
March, 2001 | FDA 483 Response | Truett Laboratories, Inc. - Form 483R, 2001-06-04 |
March, 2001 | FDA 483 | Truett Laboratories, Inc. - Form 483, 2001-03-16 |
June, 2001 | FDA 483 | Amgen, Inc - Form 483, 2001-06-08 |
March, 2001 | EIR | Truett Laboratories, Inc. - EIR, 2001-03-16 |
June, 2001 | FDA 483 Response | Amgen, Inc - Form 483R, 2001-06-21 |
November, 2001 | FDA 483 | Bachem Americas, Inc. - Form 483, 2001-11-27 |
November, 2001 | EIR | Bachem Americas, Inc. - EIR, 2001-11-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more